Chemical Properties of Deuteroporphyrin-IX dimethyl ester, bis(trimethylsiloxy)silicon(IV) derivative

Deuteroporphyrin-IX dimethyl ester, bis(trimethylsiloxy)silicon(IV) derivative

PDF Excel Molecule Calculator
InChI
InChI=1S/C38H50N4O4Si2/c1-23-17-27-19-32-25(3)29(13-15-37(43)45-5)33(40-32)21-36-30(14-16-38(44)46-6)26(4)35(42(36)48(10,11)12)22-34-24(2)18-28(20-31(23)39-27)41(34)47(7,8)9/h17-22H,13-16H2,1-12H3/b27-19-,28-20-,31-20-,32-19-,33-21-,34-22-,35-22-,36-21-
InChI Key
WRAJCWQFWYBLPA-GQCZFTIJSA-N
Formula
C38H50N4O4Si2
SMILES
COC(=O)CCC1=C(C)c2cc3nc(cc4cc(C)c(cc5c(C)c(CCC(=O)OC)c(cc1n2)n5[Si](C)(C)C)n4[Si](C)(C)C)C(C)=C3
Molecular Weight1
683.00
Cheméo is a service of Céondo GmbH, since 2007, we provide simulation, modelling and software development services for the industry. Do not hesitate to contact us for your projects.

Physical Properties

Property Value Unit Source
log10WS -8.16 Crippen Calculated Property
logPoct/wat 8.794 Crippen Calculated Property
Inp [3850.00; 3850.00]   Show Hide
Inp 3850.00 NIST
Inp 3850.00 NIST

Similar Compounds

QUINIDINE, M(HO-), AC. Strychnine. 3-O,6-O,N-Triacetylnormorphine. Benzylmorphine. Nicocodine. Buprenorphine. Dihydroergokryptine. Crinan-11-ol, 1,2-didehydro-3-methoxy-, (3«beta»,5«alpha»,11R,13«beta»,19«alpha»)-. [2,2'-Bimorphinan]-3,3',6,6'-tetrol, 7,7',8,8'-tetradehydro-4,5:4',5'-diepoxy-17,17'-dimethyl-, (5«alpha»,6«alpha»)-(5'«alpha»,6'«alpha»)-. Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5«alpha»,6«alpha»)-, bis(trifluoroacetate) (ester). Triazolo[4,5-d]pyrimidin-7-ol,3h-v-, 5-amino-3-(2',3'-o-isopropylidene-beta-d-ribofuranosyl)-, 5'-diphenyl phosphate (keto form). Deserpidine. Paclitaxel. Ergotaman-3',6',18-trione, 9,10-dihydro-12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'«alpha»,10«alpha»)-. Ergotamine.

Find more compounds similar to Deuteroporphyrin-IX dimethyl ester, bis(trimethylsiloxy)silicon(IV) derivative.

Sources

Note: Cheméo is only indexing the data, follow the source links to retrieve the latest data. The source is also providing more information like the publication year, authors and more. Take the time to validate and double check the source of the data.